journal article·2023-12

Recent progress in fluorescent probes for transthyretin sensing

Zhiyu Xie, Fantao Sun, Marco Pistolozzi, Jinwu Yan

Dyes and Pigments· Volume 220
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Amyloidosis: Diagnosis, Treatment, Outcomes · Peptidase Inhibition and Analysis · Protein Interaction Studies and Fluorescence Analysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies10.1046/j.1365-2796.2003.01262.x ↗
2. Review: history of the amyloid fibril10.1006/jsbi.2000.4221 ↗
3. Molecular pathogenesis of protein misfolding diseases: pathological molecular environments versus quality control systems against misfolded proteins10.1093/jb/mvp119 ↗
4. Protein misfolding, functional amyloid, and human disease10.1146/annurev.biochem.75.101304.123901 ↗
5. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution10.1007/s00109-003-0464-5 ↗
6. Neuromuscular amyloidosis: unmasking the master of disguise10.1002/mus.27150 ↗
7. Detection and characterization of aggregates, prefibrillar amyloidogenic oligomers, and protofibrils using fluorescence spectroscopy10.1529/biophysj.104.049700 ↗
8. Spectroscopic characterization of diverse amyloid fibrils in vitro by the fluorescent dye Nile red10.1039/c0mb00236d ↗
9. Bifunctional coumarin derivatives that inhibit transthyretin amyloidogenesis and serve as fluorescent transthyretin folding sensors10.1039/c3cc44667k ↗
10. A highly sensitive fluorescent probe that quantifies transthyretin in human plasma as an early diagnostic tool of Alzheimer's disease10.1039/C9CC04172A ↗
11. A quinoline derived D-A-D type fluorescent probe for sensing tetrameric transthyretin10.1016/j.bmcl.2021.128408 ↗
12. A quinoline–benzothiazole hybrid as the first near-infrared fluorescent probe for transthyretin10.1039/D1NJ02472H ↗
13. A stilbene that binds selectively to transthyretin in cells and remains dark until it undergoes a chemoselective reaction to create a bright blue fluorescent conjugate10.1021/ja104999v ↗
14. A competition assay to identify amyloidogenesis inhibitors by monitoring the fluorescence emitted by the covalent attachment of a stilbene derivative to transthyretin10.1016/j.bmc.2010.12.050 ↗
15. Novel trans -Stilbene-based fluorophores as probes for spectral discrimination of native and protofibrillar transthyretin10.1021/acschemneuro.6b00062 ↗
16. Trans -stilbenoids with extended fluorescence lifetimes for the characterization of amyloid fibrils10.1021/acsomega.7b00535 ↗
17. A fluorogenic aryl fluorosulfate for intraorganellar transthyretin imaging in living cells and in Caenorhabditis elegans10.1021/jacs.5b03042 ↗
18. Binding and stabilization of transthyretin by curcumin10.1016/j.abb.2009.02.013 ↗
19. Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 Å10.1016/0022-2836(78)90368-6 ↗
20. Structure of monomeric transthyretin carrying the clinically important T119M mutation10.1002/anie.201608516 ↗
21. Thermodynamic stability and aggregation kinetics of EF helix and EF loop variants of transthyretin10.1021/acs.biochem.1c00073 ↗
22. Structures of human transthyretin complexed with thyroxine at 2.0 Å resolution and 3’,5’-dinitro- N -acetyl- L -thyronine at 2.2 Å resolution10.1107/S0907444996003046 ↗
23. Transthyretin quaternary and tertiary structural changes facilitate misassembly into amyloid
24. Transthyretin amyloidogenesis inhibitors: from discovery to current developments10.1021/acs.jmedchem.0c00934 ↗
25. Diagnosis and treatment of transthyretin cardiac amyloidosis. Progress and hope10.1016/j.recesp.2017.05.018 ↗
26. Cardiac amyloidosis: an update on diagnosis and treatment10.3949/ccjm.84.s3.02 ↗
27. Designing transthyretin mutants affecting tetrameric structure: implications in amyloidogenicity10.1042/bj3480167 ↗
28. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid10.1021/bi952501g ↗
29. Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implications for wild-type, V30M, and L55P amyloid fibril formation10.1021/bi981876+ ↗
30. Overview of current and emerging therapies for amyloid transthyretin cardiomyopathy10.1016/j.amjcard.2022.10.014 ↗
31. Screening for transthyretin amyloid cardiomyopathy in everyday practice
32. Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis10.1161/CIRCULATIONAHA.116.024438 ↗
33. Cardiac amyloidosis: an update on pathophysiology, diagnosis, and treatment10.1016/j.tcm.2017.07.004 ↗
34. Cardiac amyloidosis: the great pretender10.1007/s10741-015-9480-0 ↗
35. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis10.1136/heartjnl-2012-302353 ↗
36. Contribution of electrocardiogram in the differentiation of cardiac amyloidosis and nonobstructive hypertrophic cardiomyopathy10.1536/ihj.15-005 ↗
37. Modification of methods to use Congo-red stain to simultaneously visualize amyloid plaques and tangles in human and rodent brain tissue sections10.1007/s11011-020-00608-0 ↗
38. Tc-99m-PYP imaging for cardiac amyloidosis: defining the best protocol before the flood gates burst10.1007/s12350-020-02273-3 ↗
39. Plasma neurofilament light chain: an early biomarker for hereditary ATTR amyloid polyneuropathy10.1080/13506129.2019.1708716 ↗
40. Use of biomarkers to diagnose and manage cardiac amyloidosis10.1002/ejhf.2113 ↗
41. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders10.1038/leu.2008.307 ↗
42. Measurement of prealbumin as index of protein-calorie malnutrition10.1016/S0140-6736(72)91596-6 ↗
43. The genetics of cardiac amyloidosis10.1007/s10741-021-10164-z ↗
44. Proteomics and mass spectrometry in the diagnosis of renal amyloidosis10.1093/ckj/sfv087 ↗
45. The importance of genetic counselling in genome-wide sequencing10.1038/s41576-018-0057-3 ↗
46. Progression of transthyretin (TTR) amyloidosis in donors and recipients after domino liver transplantation-a prospective single-center cohort study10.1111/tri.13326 ↗
47. Towards targets and treatments in transthyretin amyloidosis10.1080/21678707.2017.1360181 ↗
48. Discovering transthyretin amyloid fibril inhibitors by limited screening10.1016/S0968-0896(98)00130-8 ↗
49. Flavonoid administration immediately displaces thyroxine (T 4) from serum transthyretin, increases serum free T 4 , and decreases serum thyrotropin in the rat10.1210/endo-126-6-2890 ↗
50. The binding of xanthone derivatives to transthyretin10.1016/j.bcp.2005.09.012 ↗
51. Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade10.1073/pnas.1121005109 ↗
52. AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin10.1073/pnas.1300761110 ↗
53. Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity10.1038/ncomms10787 ↗
54. Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis10.1021/jm030347n ↗
55. Transthyretin stabilization by AG10 in symptomatic transthyretin amyloid cardiomyopathy10.1016/j.jacc.2019.03.012 ↗
56. First‐in‐Human study of AG10, a novel, oral, specific, selective, and potent transthyretin stabilizer for the treatment of transthyretin amyloidosis: a phase 1 safety, tolerability, pharmacokinetic, and pharmacodynamic study in healthy adult volunteers10.1002/cpdd.700 ↗
57. Tolcapone, a selective catechol- O -methyltransferase inhibitor for treatment of Parkinson's disease10.1592/phco.19.1.6.30516 ↗
58. Transthyretin stabilization activity of the catechol- O -methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study10.1080/13506129.2019.1597702 ↗
59. Detection of tolcapone in the cerebrospinal fluid of parkinsonian subjects10.1007/s002109900168 ↗
60. Tolcapone, a potent aggregation inhibitor for the treatment of familial leptomeningeal amyloidosis10.1111/febs.15339 ↗
61. Cost-effectiveness of tafamidis therapy for transthyretin amyloid cardiomyopathy10.1161/CIRCULATIONAHA.119.045093 ↗
62. The Swedish open-label diflunisal trial (DFNS01) on hereditary transthyretin amyloidosis and the impact of amyloid fibril composition10.1080/13506129.2019.1593133 ↗
63. Constructing and exploiting the fluorescent protein paintbox (nobel lecture)10.1002/anie.200901916 ↗
64. Green fluorescent protein as a marker for gene expression10.1126/science.8303295 ↗
65. Fluorescent probes for super-resolution imaging in living cells10.1038/nrm2531 ↗
66. Reversible site-selective labeling of membrane proteins in live cells10.1038/nbt954 ↗
67. A FlAsH-based FRET approach to determine G protein–coupled receptor activation in living cells10.1038/nmeth742 ↗
68. Labeling of fusion proteins with synthetic fluorophores in live cells10.1073/pnas.0401923101 ↗
69. HaloTag: a novel protein labeling technology for cell imaging and protein analysis10.1021/cb800025k ↗
70. Surveying polypeptide and protein domain conformation and association with FlAsH and ReAsH10.1038/nchembio.2007.49 ↗
71. Expanding the repertoire of fluorescent calcium sensors10.1021/cb9000525 ↗
72. Fluorescent biosensors of protein function10.1016/j.cbpa.2008.01.020 ↗
73. Molecular mechanism of Thioflavin-T binding to amyloid fibrils10.1016/j.bbapap.2010.04.001 ↗
74. [18] Quantification of β-sheet amyloid fibril structures with thioflavin T
75. Thioflavine T interaction with amyloid β-sheet structures10.3109/13506129509031881 ↗
76. On the binding of Thioflavin-T to HET-s amyloid fibrils assembled at pH 210.1016/j.jsb.2008.02.002 ↗
77. Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavine T10.1016/0003-2697(89)90046-8 ↗
78. IMM-H004, a novel courmarin derivative, protects against oxygen-and glucose-deprivation/restoration-induced apoptosis in PC12 cells10.1016/j.ejphar.2013.11.023 ↗
79. Esculetin, a coumarin derivative, prevents thrombosis: inhibitory signaling on PLCγ2–PKC–AKT activation in human platelets10.3390/ijms20112731 ↗
80. Bright ideas for chemical biology10.1021/cb700248m ↗
81. Feruloyl-CoA 6’-hydroxylase1-dependent coumarins mediate iron acquisition from alkaline substrates in arabidopsis10.1104/pp.113.228544 ↗
82. Fluorescent dyes and their supramolecular host/guest complexes with macrocycles in aqueous solution10.1021/cr200213s ↗
83. A simple and effective coumarin-based fluorescent probe for cysteine10.1016/j.bios.2014.03.018 ↗
84. Applications of light-responsive systems for cancer theranostics10.1021/acsami.8b01114 ↗
85. A colorimetric and fluorescent probe for detecting intracellular biothiols10.1016/j.bios.2016.04.098 ↗
86. A colorimetric and fluorescent probe for detecting intracellular GSH10.1016/j.bios.2015.04.016 ↗
87. Coumarin-based turn-on fluorescence probe for specific detection of glutathione over cysteine and homocysteine10.1021/acsami.5b01934 ↗
88. Bioimaging of glutathione with a two-photon fluorescent probe and its potential application for surgery guide in laryngeal cancer10.1021/acssensors.9b02118 ↗
89. A coumarin-based fluorescent probe for specific detection of cysteine in the lysosome of living cells10.1016/j.bioorg.2021.105558 ↗
90. A quick response fluorescent probe based on coumarin and quinone for glutathione and its application in living cells10.1016/j.aca.2016.04.003 ↗
91. A biomimetic approach for enhancing the in vivo half-life of peptides10.1038/nchembio.1907 ↗
92. A very short route to enantiomerically pure coumarin-bearing fluorescent amino acids10.1002/ange.200454116 ↗
93. An RGB-emitting molecular cocktail for the detection of bacterial fingerprints10.1039/D0SC01704C ↗
94. Imaging protein–protein interactions inside living cells via interaction-dependent fluorophore ligation10.1021/ja206435e ↗
95. Bioconversion of biologically active indole derivatives with indole-3-acetic acid-degrading enzymes from caballeronia glathei DSM5001410.3390/biom10040663 ↗
96. Recent advances in the application of indoles in multicomponent reactions10.1039/C7RA13321A ↗
97. B(C 6 F 5) 3 -catalyzed (convergent) disproportionation reaction of indoles10.1021/jacs.7b03534 ↗
98. A rapid and specific method for the detection of indole in complex biological samples
99. Indole diterpenoid natural products as the inspiration for new synthetic methods and strategies10.1039/C7SC01248A ↗
100. Role of indole scaffolds as pharmacophores in the development of anti-lung cancer agents10.3390/molecules25071615 ↗